Parsons PG - Search Results

1

Reduced expression of retinoblastoma gene product (pRB) and high expression of p53 are associated with poor prognosis in ovarian cancer.

Dong Y, Walsh MD, McGuckin MA, Cummings MC, Gabrielli BG, Wright GR, Hurst T, Khoo SK, Parsons PG. Dong Y, et al. Among authors: parsons pg. Int J Cancer. 1997 Aug 22;74(4):407-15. doi: 10.1002/(sici)1097-0215(19970822)74:4<407::aid-ijc8>3.0.co;2-z. Int J Cancer. 1997. PMID: 9291430

2

Expression profiling correlates with treatment response in women with advanced serous epithelial ovarian cancer.

Newton TR, Parsons PG, Lincoln DJ, Cummings MC, Wyld DK, Webb PM, Green AC, Boyle GM. Newton TR, et al. Among authors: parsons pg. Int J Cancer. 2006 Aug 15;119(4):875-83. doi: 10.1002/ijc.21823. Int J Cancer. 2006. PMID: 16557592 Clinical Trial.

3

Measurement of tumor cell activity in short-term primary culture. Clinical significance in women with ovarian cancer.

Khoo SK, Hurst T, Webb MJ, Dickie G, Kearsley J, Parsons PG, Mackay EV. Khoo SK, et al. Among authors: parsons pg. Cancer. 1988 Apr 15;61(8):1579-86. doi: 10.1002/1097-0142(19880415)61:8<1579::aid-cncr2820610815>3.0.co;2-9. Cancer. 1988. PMID: 3349421

4

Increased expression of cyclin-dependent kinase inhibitor 2 (CDKN2A) gene product P16INK4A in ovarian cancer is associated with progression and unfavourable prognosis.

Dong Y, Walsh MD, McGuckin MA, Gabrielli BG, Cummings MC, Wright RG, Hurst T, Khoo SK, Parsons PG. Dong Y, et al. Among authors: parsons pg. Int J Cancer. 1997 Feb 20;74(1):57-63. doi: 10.1002/(sici)1097-0215(19970220)74:1<57::aid-ijc10>3.0.co;2-f. Int J Cancer. 1997. PMID: 9036870

5

Expression of MUC1 and MUC2 mucins in epithelial ovarian tumours.

Dong Y, Walsh MD, Cummings MC, Wright RG, Khoo SK, Parsons PG, McGuckin MA. Dong Y, et al. Among authors: parsons pg. J Pathol. 1997 Nov;183(3):311-7. doi: 10.1002/(SICI)1096-9896(199711)183:3<311::AID-PATH917>3.0.CO;2-2. J Pathol. 1997. PMID: 9422987

6

In vitro sensitivity of ovarian cancer as determined by a short-term biochemical assay: comparison between primary and metastatic sites in the same patient.

Khoo SK, Hurst T, Lark J, Webb MJ, Parsons P, Mackay EV. Khoo SK, et al. Gynecol Oncol. 1989 Feb;32(2):151-5. doi: 10.1016/s0090-8258(89)80026-5. Gynecol Oncol. 1989. PMID: 2910775

7

Serial D-dimer levels in the assessment of tumor mass and clinical outcome in ovarian cancer.

Khoo SK, Rylatt DB, Parsons P, Wilson K, Webb MJ, Dickie G, Kearsley J, Mackay EV. Khoo SK, et al. Gynecol Oncol. 1988 Feb;29(2):188-98. doi: 10.1016/0090-8258(88)90213-2. Gynecol Oncol. 1988. PMID: 3338671

8

Prognostic significance of tumor ploidy in patients with advanced ovarian carcinoma.

Khoo SK, Hurst T, Kearsley J, Dickie G, Free K, Parsons PG, Whitaker S, Ward B. Khoo SK, et al. Among authors: parsons pg. Gynecol Oncol. 1990 Dec;39(3):284-8. doi: 10.1016/0090-8258(90)90253-h. Gynecol Oncol. 1990. PMID: 2258072

9

Cisplatin chemotherapy of ovarian cancer: is short-term in vitro chemosensitivity predictive of long-term patient survival?

Khoo SK, Hurst T, Webb MJ, Dickie G, Kearsley J, Parsons PG, Mackay EV. Khoo SK, et al. Among authors: parsons pg. Aust N Z J Obstet Gynaecol. 1988 Nov;28(4):313-7. doi: 10.1111/j.1479-828x.1988.tb01689.x. Aust N Z J Obstet Gynaecol. 1988. PMID: 3250450

10

CDKN2A/p16 is inactivated in most melanoma cell lines.

Castellano M, Pollock PM, Walters MK, Sparrow LE, Down LM, Gabrielli BG, Parsons PG, Hayward NK. Castellano M, et al. Among authors: parsons pg. Cancer Res. 1997 Nov 1;57(21):4868-75. Cancer Res. 1997. PMID: 9354451

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

252 results

Search Page

Filters